Journal Home > Volume 1 , Issue 2
Objective

To fully understand the overall system and implementation of antimicrobial stewardship (AMS) at different levels in China, an evaluation according to the integrated AMS evaluation tool developed by World Health Organization (WHO) was conducted.

Methods

A comprehensive search on the AMS relevant government policies, regulations, scientific research results, public and social activities was conducted, and the implementation of AMS strategies in national, subnational and hospital level were evaluated by the standards of the WHO.

Results

The results shew that the system construction, technical infrastructure and actions of AMS in China at the national level is relatively satisfied, but the AMS system needs to be further strengthened at the subnational and the medical institutional level, especially the integration of multidisciplinary teams and relevant departments; the implementation of professional intervention strategies, national education and publicity, professional education and training are relatively weak. AMS implementation is mainly promoted at the national level, and AMS in primary medical institutions is almost missing. It is necessary to carry out AMS at the provincial level and medical institutions as soon as possible. The focus is to establish a professional AMS team, prepare AMS guideline, implement AMS strategy, raise public awareness and ensure the long‐term and sustainable development of AMS in the country.

Conclusion

The Chinese government has established a system for AMS, and implemented a multisectoral coordinative mechanism. However, at the subnational and district levels, an AMS system and practice should be set up soon to promote the rational use of antibiotics.


menu
Abstract
Full text
Outline
About this article

Evaluating the integrated antimicrobial stewardship system of China by the assessment tool of WHO

Show Author's information Yonghong Xiao1( )Wei Yu1Tingting Xiao1Ping Shen1
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center of Infectious Diseases, The First affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China

Abstract

Objective

To fully understand the overall system and implementation of antimicrobial stewardship (AMS) at different levels in China, an evaluation according to the integrated AMS evaluation tool developed by World Health Organization (WHO) was conducted.

Methods

A comprehensive search on the AMS relevant government policies, regulations, scientific research results, public and social activities was conducted, and the implementation of AMS strategies in national, subnational and hospital level were evaluated by the standards of the WHO.

Results

The results shew that the system construction, technical infrastructure and actions of AMS in China at the national level is relatively satisfied, but the AMS system needs to be further strengthened at the subnational and the medical institutional level, especially the integration of multidisciplinary teams and relevant departments; the implementation of professional intervention strategies, national education and publicity, professional education and training are relatively weak. AMS implementation is mainly promoted at the national level, and AMS in primary medical institutions is almost missing. It is necessary to carry out AMS at the provincial level and medical institutions as soon as possible. The focus is to establish a professional AMS team, prepare AMS guideline, implement AMS strategy, raise public awareness and ensure the long‐term and sustainable development of AMS in the country.

Conclusion

The Chinese government has established a system for AMS, and implemented a multisectoral coordinative mechanism. However, at the subnational and district levels, an AMS system and practice should be set up soon to promote the rational use of antibiotics.

Keywords: evaluation, China, antimicrobial stewardship

References(36)

The Review of Antimicrobial Resistance. Tackling drug resistant infections globally: final report and recommendations. 2016. https://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf
Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–55.
WHO. Global action plan on antimicrobial resistance. 2015. Available from: https://www.who.int/publications/i/item/9789241509763
WHO. Antimicrobial stewardship programmes in health‐care facilities in low‐ and middle‐income countries. A WHO practical toolkit. 2019. Available from: https://apps.who.int/iris/bitstream/handle/10665/329404/9789241515481-eng.pdf
NHC. Notice of the General Office of the Ministry of Health on special campaign for the clinical use of antibiotics in China. 2011. Available from: http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=51376
NHC. Administrative regulations for the clinical use of antibiotics. 2012. http://www.nhc.gov.cn/wjw/c100022/202201/8fcae32c3f1f467eb795ee816e2387d6.shtml
NHC. Notice on issuing the National Action Plan to Contain AMR (2016–2020). 2016. http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=f1ed26a0c8774e1c8fc89dd481ec84d7
WHO. WHO policy guidance on integrated antimicrobial stewardship activities. 2021. Available from: https://www.who.int/publications/i/item/9789240025530
DOI
NHC. Notice of the National Health Commission on Further Strengthening the management of antimicrobial drugs and curbing drug resistance. 2021. Available from: http://www.nhc.gov.cn/yzygj/s7659/202104/0a5f9d529e1d4f60a3f73abcb29410d0.shtml
NHC. Notice on issuing the principles for clinical use of antimicrobial agents. 2015. Available from: http://www.nhc.gov.cn/yzygj/s3593/201508/c18e1014de6c45ed9f6f9d592b43db42.shtml
NHC.National Essential Medicine List. 2018. Available from: http://www.nhc.gov.cn/wjw/jbywml/201810/600865149f4740eb8ebe729c426fb5d7.shtml
The State Council.Opinions of the General Office of the State Council on the evaluation of the consistency of quality and efficacy of generic drugs. 2016. Available from: http://www.gov.cn/zhengce/content/2016-03/05/content_5049364.htm
The State Council. A pilot program for centralized drug procurement and use. 2019. Available from: http://www.gov.cn/zhengce/content/2019-01/17/content_5358604.htm
NHC. The establishment of bacterial drug resistance and clinical use of antibiotics surveillance network. 2005. Available from: http://www.nhc.gov.cn/wjw/zcjd/201304/b0da0ebfc7b3428f98d435a29cfa4250.shtml
NPC Standing Committee. Drug Administrative Act. 2015. Available from: https://www.nmpa.gov.cn/yaopin/ypfgwj/ypflxzhfg/20150424120001309.html
Gong Y, Jiang N, Chen Z, Wang J, Zhang J, Feng J, et al. Over‐the‐counter antibiotic sales in community and online pharmacies, China. Bull World Health Organ. 2020;98(7):449–57.
NHC.“World Antimicrobial Awareness Week” was officially launched. 2017. Available from: http://www.nhc.gov.cn/yzygj/jdt/201711/c3f7083ccb1d49798817e49dcebb1d99.shtml
NIHA. The first Guangzhou training course for clinical pharmacists in the diagnosis and treatment of bacterial and fungal infections (Peiying program) opened. 2017. Available from: http://www.niha.org.cn/hwaciis/news/publish/sevenInner?id=401&title10.1016/S1473-3099(16)30388-7
DOI
MOHURD. Announcement on issuing Code for Architectural Design of General Hospitals. 2014. Available from: https://www.mohurd.gov.cn/gongkai/fdzdgknr/tzgg/201412/20141209_224354.html
NHC. Administrative regulations for healthcare quality. 2016. Available from: http://www.nhc.gov.cn/wjw/c100022/202201/922894b1072d4a8a91249407fea2471e.shtml
NHC. The current situation of clinical application management and bacterial resistance of antibiotics in China was published. 2016. Available from: http://www.nhc.gov.cn/yzygj/s3594/201611/a2b9bca213a74ce88a21571795bdc13a.shtml
Xiao Y, Li L. China's national plan to combat antimicrobial resistance. Lancet Infect Dis. 2016;16(11):1216–18.
NHC. The second meeting of the joint working mechanism for prevention and control of bacterial drug resistance was held in 2016. 2016. Available from: http://www.nhc.gov.cn/yzygj/s3594/201701/f6c25492531c41b9a9c30c073d5c15aa.shtml
NHC. Administrative regulations of hospital infection. 2006. Available from: http://www.nhc.gov.cn/wjw/c100022/202201/22d85ce0b5f441d094538aff835c1aca.shtml
NHC. Administrative regulations for prescription. 2007. Available from: http://www.nhc.gov.cn/fzs/s3576/201808/d71d4735f6c842158d2757fbaa553b80.shtml
NHC. Notice of the General Office of the National Health and Family Planning Commission on further strengthening the management of clinical application of antibiotics and curbing bacterial resistance. 2017. Available from: http://www.nhc.gov.cn/yzygj/s7659/201703/d2f580480cef4ab1b976542b550f36cf.shtml
Zhang C, Li S, Ji J, Shen P, Ying C, Li L, et al. The professional status of infectious disease physicians in China: a nationwide cross‐sectional survey. Clin Microbiol Infect. 2017;24(1):82.e5–82.e10.
Xiao Y, Shen P, Zheng B, Zhou K, Luo Q, Li L. Change in antibiotic use in secondary and tertiary hospitals nationwide after a national antimicrobial stewardship campaign was launched in China, 2011–2016: an observational study. J Infect Dis. 2020;221(Suppl 2):S148–55.
Zhou J, Ma X. A survey on antimicrobial stewardship in 116 tertiary hospitals in China. Clin Microbiol Infect. 2019;25(6):759.e9–e14.
Ji W, Hayat K, Ye D, Mciver DJ, Yan K, Kadirhaz M, et al. Antimicrobial stewardship programs in Northwest China: a cross‐sectional survey of perceptions, involvement, and perceived barriers among hospital pharmacists. Front Pharmacol. 2021;12:616503.
NHC. Guideline for the diagnosis and treatment of Covid‐19 (the ninth tentative version). 2022. Available from: http://www.nhc.gov.cn/yzygj/s7653p/202203/b74ade1ba4494583805a3d2e40093d88.shtml
DOI
Xiao Y. Antimicrobial stewardship in China: systems, actions and future strategies. Clin Infect Dis. 2018;67(Suppl_2):S135–41.
Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 28 March 2022
Accepted: 10 August 2022
Published: 13 September 2022
Issue date: October 2022

Copyright

© 2022 The Authors.

Acknowledgements

This study was supported in part by grants from the Key Research and Development Program of Zhejiang Province (2021C03068).

Rights and permissions

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Return